Emerging evidence suggests that SARS-CoV-2 can drive a diverse array of immune processes, raising the risk that immunosuppressant agents that are in clinical trials might be effective for some patients but detrimental for others.

中文翻译：

---

免疫状态可以决定COVID-19治疗的疗效。

新兴证据表明，SARS-CoV-2可以驱动多种免疫过程，从而增加了临床试验中的免疫抑制剂可能对某些患者有效而对其他患者有害的风险。